Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2008-01-10

Original market date: See footnote 1

1996-08-14

Product name:

LYPHOLYTE

DIN:

02139618 Electronic product monograph is not available

Company:

PHARMACEUTICAL PARTNERS OF CANADA INC
45 Vogell Road, Suite 200
Richmond Hill
Ontario
Canada L4B 3P6

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

6

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05XA30 COMBINATIONS OF ELECTROLYTES

Active ingredient group (AIG) number:See footnote5

0610335002

List of active ingredient(s)
Active ingredient(s) Strength
CALCIUM ACETATE 440 MG / 20 ML
MAGNESIUM ACETATE 860 MG / 20 ML
POTASSIUM ACETATE 690 MG / 20 ML
POTASSIUM CHLORIDE 2.5 G / 20 ML
SODIUM ACETATE 2.7 G / 20 ML
SODIUM GLUCONATE 1.1 G / 20 ML
Version 4.0.2
Date modified: